Literature DB >> 22180088

c-Jun, at the crossroad of the signaling network.

Qinghang Meng1, Ying Xia.   

Abstract

c-Jun, the most extensively studied protein of the activator protein-1 (AP-1) complex, is involved in numerous cell activities, such as proliferation, apoptosis, survival, tumorigenesis and tissue morphogenesis. Earlier studies focused on the structure and function have led to the identification of c-Jun as a basic leucine zipper (bZIP) transcription factor that acts as homo- or heterodimer, binding to DNA and regulating gene transcription. Later on, it was shown that extracellular signals can induce post-translational modifications of c-Jun, resulting in altered transcriptional activity and target gene expression. More recent work has uncovered multiple layers of a complex regulatory scheme in which c-Jun is able to crosstalk, amplify and integrate different signals for tissue development and disease. One example of such scheme is the autocrine amplification loop, in which signal-induced AP-1 activates the c-Jun gene promoter, while increased c-Jun expression feedbacks to potentiate AP-1 activity. Another example of such scheme, based on recent characterization of gene knockout mice, is that c-Jun integrates signals of several developmental pathways, including EGFR-ERK, EGFR-RhoA-ROCK, and activin B-MAP3K1-JNK for embryonic eyelid closure. After more than two decades of extensive research, c-Jun remains at the center stage of a molecular network with mysterious functional properties, some of which are yet to be discovered. In this article, we will provide a brief historical overview of studies on c-Jun regulation and function, and use eyelid development as an example to illustrate the complexity of c-Jun crosstalking with signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180088      PMCID: PMC4875184          DOI: 10.1007/s13238-011-1113-3

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  100 in total

1.  Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.

Authors:  T Smeal; B Binetruy; D Mercola; A Grover-Bardwick; G Heidecker; U R Rapp; M Karin
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

Review 2.  Psoriasis: what we have learned from mouse models.

Authors:  Erwin F Wagner; Helia B Schonthaler; Juan Guinea-Viniegra; Erwin Tschachler
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

3.  c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.

Authors:  G Behre; A J Whitmarsh; M P Coghlan; T Hoang; C L Carpenter; D E Zhang; R J Davis; D G Tenen
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

Review 4.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

5.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

6.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

7.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation.

Authors:  A Behrens; M Sibilia; E F Wagner
Journal:  Nat Genet       Date:  1999-03       Impact factor: 38.330

8.  Induction of protooncogene c-jun by serum growth factors.

Authors:  K Ryder; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells.

Authors:  E Nikolakaki; P J Coffer; R Hemelsoet; J R Woodgett; L H Defize
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

10.  Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development.

Authors:  Manuela Uda; Chris Ottolenghi; Laura Crisponi; Jose Elias Garcia; Manila Deiana; Wendy Kimber; Antonino Forabosco; Antonio Cao; David Schlessinger; Giuseppe Pilia
Journal:  Hum Mol Genet       Date:  2004-03-31       Impact factor: 6.150

View more
  73 in total

1.  Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK.

Authors:  A Geissler; F Haun; D O Frank; K Wieland; M M Simon; M Idzko; R J Davis; U Maurer; C Borner
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

2.  Activation of adrenergic receptor in H9c2 cardiac myoblasts co-stimulates Nox2 and the derived ROS mediate the downstream responses.

Authors:  Nikhat Saleem; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.396

3.  Transcriptional profiling reveals elevated Sox2 in DNA polymerase ß null mouse embryonic fibroblasts.

Authors:  Jianfeng Li; Soumya Luthra; Xiao-Hong Wang; Uma R Chandran; Robert W Sobol
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

4.  Glutathione peroxidase-1 inhibits transcription of regenerating islet-derived protein-2 in pancreatic islets.

Authors:  Jun-Won Yun; Zeping Zhao; Xi Yan; Marko Z Vatamaniuk; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2019-01-28       Impact factor: 7.376

5.  Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitination and degradation of c-Jun.

Authors:  Jing Yang; Min Huang; Liang Zhou; Xian He; Xiaogang Jiang; Yang Zhang; Guoqiang Xu
Journal:  J Biol Chem       Date:  2018-05-10       Impact factor: 5.157

6.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.

Authors:  Lichao Hu; Longfei Xia; Hong Zhou; Biao Wu; Yuan Mu; Ying Wu; Jinchuan Yan
Journal:  Tumour Biol       Date:  2013-04-25

7.  Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs' endothelial corneal dystrophy.

Authors:  Mario Matthaei; Jianfei Hu; Huan Meng; Eva-Maria Lackner; Charles G Eberhart; Jiang Qian; Haiping Hao; Albert S Jun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-15       Impact factor: 4.799

8.  miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.

Authors:  Lijoy K Mathew; Nicolas Skuli; Vera Mucaj; Samuel S Lee; Pascal O Zinn; Pratheesh Sathyan; Hongxia Z Imtiyaz; Zhongfa Zhang; Ramana V Davuluri; Shilpa Rao; Sriram Venneti; Priti Lal; Justin D Lathia; Jeremy N Rich; Brian Keith; Andy J Minn; M Celeste Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

9.  Association analyses of insulin signaling pathway gene polymorphisms with healthy aging and longevity in Americans of Japanese ancestry.

Authors:  Brian J Morris; Timothy A Donlon; Qimei He; John S Grove; Kamal H Masaki; Ayako Elliott; D Craig Willcox; Bradley J Willcox
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-06-14       Impact factor: 6.053

10.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.